AJMC June 23, 2022
Mary Caffrey

Nathan H. Walcker, MBA, CEO of Florida Cancer Specialists & Research Institute (FCS) since August 2020, discusses the future of value-based care for the practice as the Oncology Care Model comes to an end.

Nathan H. Walcker, MBA, has been CEO of Florida Cancer Specialists & Research Institute (FCS) since August 2020, after joining the practice as chief financial officer in 2019.1 As CEO, Walcker describes his priorities in leading FCS’ 4200 employees as ensuring clinical care of the highest quality, with attention to innovative treatments; convenient access to clinical trials, including early-phase drug trials; and “delivering a relentless focus on operational, clinical, and financial excellence.”

FCS was an early adopter of value-based care initiatives. For nearly a decade, its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Interview / Q&A, Payment Models, Physician, Provider, Trends, Value Based
Related Articles:
Patient Engagement Is Essential for Achieving the Goals of Value-Based Care
CMMI’s Innovations in Behavioral Health: Promoting Physical and Mental Well-being
7 Tips for making the most of value-based care
Accreditation and Value-Based Care: Leveraging Operational Excellence and Clinical Services for Patients and Your Pharmacy
Palliative Care’s Value-Based Future

Share This Article